Work for Odonate Therapeutics, Inc.?

Claim Your Profile

Odonate Therapeutics, Inc. Logo Image

Odonate Therapeutics, Inc.

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Form 10K

Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. has reached its limit for free report views.

About Odonate Therapeutics, Inc.

51-200 Employees
Based in San Diego, California

Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer.

Ticker:
ODT
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol